3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
18
Neoplasm Metastasis
10
Triple Negative Breast Neoplasms
9
Lung Neoplasms
9
Ovarian Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Endometrial Neoplasms
6
Fallopian Tube Neoplasms
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
3
Adenocarcinoma
3
Stomach Neoplasms
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vulvar Neoplasms
1
Vomiting
1
Uterine Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Recurrence
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Cystic Neoplasm
1
Pancreatic Adenocarcinoma Metastatic
1
Interventions
Radiosurgery
2
neratinib
1
lutetium Lu 177 dotatate
1
capivasertib
1
avasopasem manganese
1
Valproic Acid
1
Taxes
1
Sevoflurane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Propofol
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Gemcitabine
1
Everolimus
1
Etoposide
1
Cystectomy
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Cisplatin
1
Carboplatin
1
Blood Specimen Collection
1
Biopsy
1
Anesthesia, Inhalation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease Progression
×
Taxes
×
Clear all
NCT07049055
2026-02-27
Carolyn-USA
Engeneic Pty Limited
Phase 1/2
Recruiting
144 enrolled